Claudia Campana (C Campana)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Replacement Therapy

Reactive Oxygen Species

Transcranial Magnetic Stimulation

Diabetic Retinopathy

Top Venues

The Journal of endocrinology

European journal of endocrinology

Journal of endocrinological investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Claudia Campana, Anand M Iyer, Diego Ferone, Federico Gatto, Leo J Hofland
Somatostatin receptors and the associated intracellular machinery: the two sides of the coin. The Journal of endocrinology 260 (3) (2024)
Claudia Campana, Anand M Iyer, Diego Ferone, Federico Gatto, Leo J Hofland
Somatostatin receptors and the associated intracellular machinery: the two sides of the coin. The Journal of endocrinology 260 (3) (2024)
Claudia Campana, Anand M Iyer, Diego Ferone, Federico Gatto, Leo J Hofland
Somatostatin receptors and the associated intracellular machinery: the two sides of the coin. The Journal of endocrinology 260 (3) (2024)
Claudia Campana, Peter M van Koetsveld, Richard A Feelders, Wouter W de Herder, Anand M Iyer, Marie-Louise F van Velthuysen, Marije J Veenstra, Elisabeth S R van den Dungen, Sanne E Franck, Diego Ferone, Federico Gatto, Leo J Hofland
Digital quantification of somatostatin receptor subtype 2a immunostaining: a validation study. European journal of endocrinology 187 (3) (2022)
Claudia Campana, F Nista, L Castelletti, M Caputo, E Lavezzi, P Marzullo, A Ferrero, G Gaggero, F R Canevari, D C Rossi, G Zona, A Lania, Diego Ferone, Federico Gatto
Clinical and radiological presentation of parasellar ectopic pituitary adenomas: case series and systematic review of the literature. Journal of endocrinological investigation 45 (8) (2022)
Jessica Amarù, Federica Barbieri, Marica Arvigo, Agnese Solari, Adriana Bajetto, Federica Nista, Claudia Campana, Gabriele Gaggero, Alessandro Prior, Diego Criminelli Rossi, Gianluigi Zona, Diego Ferone, Tullio Florio, Federico Gatto
Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects. Cancers 13 (8) (2021)